Marta Aldea

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

María Sepúlveda, Marta Aldea, Domingo Escudero et al. · Multiple Sclerosis Journal · 2017 · 98 citations

Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates

Gloria P. Gómez-Pérez, Almudena Legarda, José Muñóz et al. · Malaria Journal · 2015 · 95 citations · Full text

Evaluating influenza vaccination campaigns beyond coverage: A before-after study among health care workers

Anna Llupià, Guillermo Mena, Victòria Olivé et al. · American Journal of Infection Control · 2013 · 41 citations

Vaccination, Preventive Medicine, Health Communication +11

Incidence and Impact of COVID-19 in MS

María Sepúlveda, Sara Llufriú, Eugenia Martínez‐Hernández et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 37 citations · Full text